US Drug Recall Register
Class II · Moderate risk Terminated Initiated Nov 30, 2012 (14 years ago)

Lisinopril and Hydrochlorothiazide Tablets

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Presence of Foreign Substance: Reports of gray smudges identified as minute stainless steel particulates were found in the recalled tablets.

What was recalled

Lisinopril and Hydrochlorothiazide Tablets, 20 mg/25 mg, packaged in a) 100-count tablets per bottle (NDC 0143-1264-01) and b) 1000-count tablets per bottle (NDC 0143-1264-10), Rx only, Manufactured by: West-ward Pharmaceutical Corp., Eatontown, NJ 07724.

Recalling firm
West-ward Pharmaceutical Corp.
NDC code
0143-1264-01
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-132-2013

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Hydrochlorothiazide recalls

See all
Class II · Moderate risk Ongoing

Bisoprolol Fumarate and Hydrochlorothiazide tablets

Reason cGMP Deviations: recall due to not meeting the N-Nitroso Bisoprolol impurity specification limits.

Unichem Pharmaceuticals USA Inc. NDC 29300-187-01 D-0301-2026
Class III · Low risk Ongoing

Bisoprolol Fumarate and Hydrochlorothiazide Tablets

Reason Cross Contamination with Other Products: Testing of reserve samples showed presence of traces of ezetimibe

Glenmark Pharmaceuticals Inc., USA D-0199-2026
Class II · Moderate risk Ongoing

Lisinopril and Hydrochlorothiazide Tablets USP 20mg/12.5mg

Reason Product Mix Up: This product is being recalled because of a complaint received that a sealed bottle of lisinopril and hydrochlorothiazide tablets 20mg/12.5 mg had a foreign tablet identified as atazanavir and ritonavir tablet 300mg/100mg.

Lupin Pharmaceuticals Inc. NDC 68180-519-01 D-0532-2025